About J. Michael Gonzalez-Campoy MD, PhD, FACE

Dr. Gonzalez-Campoy earned his medical degree and PhD in physiology and biophysics from the Mayo Medical School and Mayo Graduate School in Rochester, Minnesota. He received a fellowship in diabetes, endocrinology, and metabolism from the University of Minnesota. His clinical and research interests include the prevention and treatment of obesity and adiposopathy, and their complications.

Dr. Gonzalez-Campoy lectures nationally and internationally and has chaired or been an invited speaker for several national meetings on obesity and adiposopathy. He is past member of the American College of Endocrinology Board of Trustees and the American Association of Clinical Endocrinologists Board of Directors. Dr. Gonzalez supported the launch of the Association of Clinical Researchers and Educators (ACRE), which is dedicated to highlight the value of collaborative relationships between physicians and industry.

Articles Written by J. Michael Gonzalez-Campoy MD, PhD, FACE

The U.S. Food and Drug Administration (FDA) recently expanded the approved uses of Vyvanse® (lisdexamfetamine dimesylate) to include treatment of moderate-to-severe binge-eating disorder (BED) in adults.

Many people with obesity can’t simply lose weight with healthy eating and physical activity, despite how hard they may try. Bariatric (obesity) surgery is performed to treat people who have morbid obesity.

Bariatric surgery is a tool to aid in weight loss, but is not a cure. To successfully lose weight and maintain this weight loss, people who have bariatric surgery must commit to healthy eating and regular physical activity for the rest of their lives. Learn more here.

Articles Reviewed by J. Michael Gonzalez-Campoy MD, PhD, FACE

Bariatric surgery is increasingly being used to treat adolescents with severe obesity, despite limited data regarding the safety of these procedures in this age group. Now, the largest study on this topic shows that most teenagers that underwent bariatric surgery for weight loss had few short-term complications, as reported in "JAMA Pediatrics."

Financial Disclosures for J. Michael Gonzalez-Campoy MD, PhD, FACE

EndocrineWeb, a Vertical Health, LLC website, is committed to ensuring that the medical information it presents is accurate, balanced, objective, and trustworthy.

To help achieve this goal, EndocrineWeb requires all authors, editors, and reviewers to disclose any financial relationships or affiliations they have with companies whose products or services may be mentioned in the content they author, edit, or review.

The intent of this policy is to identify any perceived, potential, or real conflicts of interest so that readers can make their own judgments about the value of information being presented.

Author's Statement

I, the undersigned, declare that neither I nor members of my immediate family have a financial interests or affiliation with commercial companies whose products and / or services may be mentioned in the materials I have authored, edited or reviewed for presentation on Vertical Health, LLC’s websites.

Policy and Contact

This information is not designed to replace a physician's independent judgment about the appropriateness or
risks of a procedure for a given patient. Always consult your doctor about your medical conditions. Vertical
Health & EndocrineWeb do not provide medical advice, diagnosis or treatment. Use of this website is
conditional upon your acceptance of our user agreement.